218 related articles for article (PubMed ID: 33610928)
1. Beneficial effects of minocycline on the ovary of polycystic ovary syndrome mouse model: Molecular docking analysis and evaluation of TNF-α, TNFR2, TLR-4 gene expression.
Khajouei A; Hosseini E; Abdizadeh T; Kian M; Ghasemi S
J Reprod Immunol; 2021 Apr; 144():103289. PubMed ID: 33610928
[TBL] [Abstract][Full Text] [Related]
2. Molecular docking and mouse modeling suggest CMKLR1 and INSR as targets for improving PCOS phenotypes by minocycline.
Kian M; Hosseini E; Abdizadeh T; Langaee T; Khajouei A; Ghasemi S
EXCLI J; 2022; 21():400-414. PubMed ID: 35368462
[TBL] [Abstract][Full Text] [Related]
3. The significant improvement in ovarian PCOS syndrome using hydralazine and alendronate aromatase inhibitor FDA-approved drugs in Wistar rat models.
Kavousipour S; Koohnavard F; Shahbazi B; Eftekhar E; Ahmadi K
Biomed Pharmacother; 2024 May; 174():116504. PubMed ID: 38552442
[TBL] [Abstract][Full Text] [Related]
4. The effect of Nateglinide and Octreotide on follicular morphology and free radical scavenging system in letrazole-induced rat model of PCOS.
Kirici P; Kaplan S; Annac E; Tanriverdi ES; Cagiran FT; Kali Z; Mavral N; Taskapan MC
Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8893-8902. PubMed ID: 36524509
[TBL] [Abstract][Full Text] [Related]
5. Isorhamnetin inhibits inflammatory response to alleviate DHEA-induced polycystic ovary syndrome in rats.
Yu F; Xue Y; Zhao Y; Zhang L; He X; Liu Z
Gynecol Endocrinol; 2023 Dec; 39(1):2183045. PubMed ID: 36842967
[TBL] [Abstract][Full Text] [Related]
6. Apelin receptor modulation mitigates letrozole-induced polycystic ovarian pathogenesis in mice.
Anima B; Gurusubramanian G; Roy VK
Cytokine; 2024 Jul; 179():156639. PubMed ID: 38733946
[TBL] [Abstract][Full Text] [Related]
7. Effect of 150 kHz electromagnetic radiation on the development of polycystic ovaries induced by estradiol Valerate in Sprague Dawley rats.
Mohammed S; Sundaram V; Zyuzikov N
J Ovarian Res; 2021 Feb; 14(1):26. PubMed ID: 33546719
[TBL] [Abstract][Full Text] [Related]
8. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study.
Furat Rencber S; Kurnaz Ozbek S; Eraldemır C; Sezer Z; Kum T; Ceylan S; Guzel E
J Ovarian Res; 2018 Jun; 11(1):55. PubMed ID: 29958542
[TBL] [Abstract][Full Text] [Related]
9. Improvement of the folliculogenesis by transplantation of bone marrow mesenchymal stromal cells in mice with induced polycystic ovary syndrome.
Kalhori Z; Azadbakht M; Soleimani Mehranjani M; Shariatzadeh MA
Cytotherapy; 2018 Dec; 20(12):1445-1458. PubMed ID: 30523787
[TBL] [Abstract][Full Text] [Related]
10. Ameliorative potential of rosmarinic acid in a rat model of polycystic ovary syndrome: Targeting MCP-1 and VEGF: A histological, immunohistochemical, and biochemical study.
Shalaby AM; Shalaby RH; Elshamy AM; Alnasser SM; Alorini M; Jaber FA; Alabiad MA; Alshaikh ABA; Hassan SMA; Aziz SAMA; Safa MA; Elkholy MR
Cell Biochem Funct; 2024 Jun; 42(4):e4073. PubMed ID: 38863227
[TBL] [Abstract][Full Text] [Related]
11. Liuwei Dihuang Pills alleviate the polycystic ovary syndrome with improved insulin sensitivity through PI3K/Akt signaling pathway.
Qiu Z; Dong J; Xue C; Li X; Liu K; Liu B; Cheng J; Huang F
J Ethnopharmacol; 2020 Mar; 250():111965. PubMed ID: 31185267
[TBL] [Abstract][Full Text] [Related]
12. Ameliorative effects of fisetin in letrozole-induced rat model of polycystic ovary syndrome.
Mihanfar A; Nouri M; Roshangar L; Khadem-Ansari MH
J Steroid Biochem Mol Biol; 2021 Oct; 213():105954. PubMed ID: 34298098
[TBL] [Abstract][Full Text] [Related]
13. Soy isoflavones alleviate polycystic ovary syndrome in rats by regulating NF- κB signaling pathway.
Ma X; Li X; Ma L; Chen Y; He S
Bioengineered; 2021 Dec; 12(1):7215-7223. PubMed ID: 34546841
[TBL] [Abstract][Full Text] [Related]
14. The effect of ellagic acid on sex hormones and miRNA-21 expression in rats with polycystic ovary syndrome.
Khoshvaghti A; Rahbari R
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4263-4273. PubMed ID: 38078918
[TBL] [Abstract][Full Text] [Related]
15. ETA-mediated anti-TNF-α therapy ameliorates the phenotype of PCOS model induced by letrozole.
Lang Q; Yidong X; Xueguang Z; Sixian W; Wenming X; Tao Z
PLoS One; 2019; 14(6):e0217495. PubMed ID: 31170164
[TBL] [Abstract][Full Text] [Related]
16. Exploring the efficacy and mechanism of Bailing capsule to improve polycystic ovary syndrome in mice based on intestinal-derived LPS-TLR4 pathway.
Guan HR; Li B; Zhang ZH; Wu HS; Wang N; Chen XF; Zhou CL; Bian XR; Li L; Xu WF; He XL; Dong YJ; Jiang NH; Su J; Lv GY; Chen SH
J Ethnopharmacol; 2024 Sep; 331():118274. PubMed ID: 38697410
[TBL] [Abstract][Full Text] [Related]
17. Cryptotanshinone alleviates polycystic ovary syndrome in rats by regulating the HMGB1/TLR4/NF‑κB signaling pathway.
Yang Y; Yang L; Qi C; Hu G; Wang L; Sun Z; Ni X
Mol Med Rep; 2020 Nov; 22(5):3851-3861. PubMed ID: 32901834
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid and fibroblast growth factor-2 play a key role on modulation of sex hormones and apoptosis in a mouse model of polycystic ovary syndrome induced by estradiol valerate.
Moayeri A; Rostamzadeh A; Raoofi A; Rezaie MJ; Abasian Z; Ahmadi R
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):882-890. PubMed ID: 33218406
[TBL] [Abstract][Full Text] [Related]
19. Mitigation of letrozole induced polycystic ovarian syndrome associated inflammatory response and endocrinal dysfunction by Vitex negundo seeds.
Kar TK; Sil S; Ghosh A; Barman A; Chattopadhyay S
J Ovarian Res; 2024 Apr; 17(1):76. PubMed ID: 38589892
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of isoflavone-aglycone fraction from soybean (
Alivandi Farkhad S; Khazali H
Gynecol Endocrinol; 2019 Dec; 35(12):1078-1083. PubMed ID: 31185755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
